European collaboration for cell- and gene therapies in precision medicine
- Closes
- 27 Jan 2027
- 66 days left
- Opened
- 19 Nov 2026
- Funding per project
- up to 3 000 000 SEK
- Who can apply
- Startups, Micro companies, SMEs, Large companies, Research organisations, NGOs, Public bodies, Consortia
- Open to applicants from
- Sweden
What this call funds
Vinnova funds Swedish participants in the EP PerMed JTC 2027 international call on developing and validating cell and gene therapies. Eligible applicants are companies, academia, public sector and patient organisations with a Swedish branch, in consortia of at least three partners from three countries. Swedish partners can receive up to 3 million SEK each, or 5 million SEK in total if two Swedish partners take part, over projects of up to three years.
AI Summary written by AI (Claude (Anthropic)) from the funder's text. The rules below are quoted from the funder.
The call in detail
- Funder
- Vinnova
- Programme
- European Partnership for Personalised Medicine (EP PerMed)
- Type
- Grant
- Funding per project
- up to 3 000 000 SEK
- Eligible applicants
- Startups, Micro companies, SMEs, Large companies, Research organisations, NGOs, Public bodies, Consortia
- Eligible countries
- Sweden
- Startup relevance
- Medium
- Source
- Vinnova — open application rounds
Key dates
- 19 Nov 2026
- Applications opened
- 27 Jan 2027
- Applications close
Earlier rounds and changes
| Recorded | What changed | Details |
|---|---|---|
| 20 Nov 2026 | First listed here |
Similar open calls
Open calls like this one are listed for free accounts. Start with a free account to see them, save searches and get an e-mail when a new call matches.
Create free accountSummaries and extracted fields are generated automatically from the official page and may contain mistakes. Check the official page before applying.